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Background. Uveitis is a major cause of visual impairment throughout the world. Analysis of cytokine profiles in
aqueous humor specimens may provide insight into the physiopathological processes that underly retinal damage in
this context.
Methods. Using a multiplex assay, we determined the concentrations of 17 cytokines and chemokines in aqueous
humor specimens obtained from patients with ocular toxoplasmosis or viral uveitis and compared these concentra-
tions with those in specimens obtained from patients with noninfectious intermediate uveitis or cataract.
Results. Five mediators (interleukin [IL]– 8, monocyte chemoattractant protein–1, tumor necrosis factor–,
IL-4, and IL-10) were detected in 50% of patients in all groups. In contrast, IL-5 and IL-12 were specific for ocular
toxoplasmosis, and granulocyte monocyte colony-stimulating factor and IL-1 were specific for viral uveitis; these
mediators could present specific markers for diagnostic purposes. Interferon-, IL-6, and macrophage inflammatory
protein-1 were common markers of ocular toxoplasmosis and viral uveitis. IL-17 was a common marker of ocular
toxoplasmosis and intermediate uveitis.
Conclusions. We found specific cytokine profiles for each type of uveitis, with large interindividual variations and
no etiological or clinical correlations. Ocular cytokine mapping contributes to a better understanding of the physio-
pathology of specific forms of uveitis and provides guidance for new targeted treatment.
Uveitis is a potentially blinding inflammatory disease
that affects individuals of any age. It is the third leading
cause of blindness worldwide, accounting for 10%–15%
of blindness. Despite huge advances in diagnostic tech-
niques, many cases (35%–50%) remain idiopathic. The
agents that most frequently cause infectious uveitis are
Toxoplasma gondii and herpes simplex virus [1].
Herpes simplex virus is one of the most common in-
fectious causes of uveitis, accounting for up to 9% of
cases of anterior uveitis in published series. Herpetic
uveitis may affect the sclera, cornea, or anterior or pos-
terior uvea and can present as panuveitis [2]. The infec-
tion may manifest in an acute, chronic, or recurrent
manner. Acute anterior herpetic uveitis is frequently as-
sociated with corneal involvement but may also occur
without corneal inflammation [3].
Ocular toxoplasmosis is a major cause of visual im-
pairment throughout the world. It accounts for 30%–
50% of all cases of posterior uveitis; the estimated
incidence rate in the United Kingdom is 0.4 cases per
100,000 persons per year [4]. In southern Brazil,
17.7% of individuals have been found to have retinal
lesions compatible with ocular toxoplasmosis [5].
These figures may not represent the entire burden of
ocular toxoplasmosis, because ocular toxoplasmosis
is often asymptomatic and biological confirmation is
not systematically sought. Necrotizing retinocho-
roiditis and retinochoroidal scars are the hallmarks of
ocular toxoplasmosis and are commonly accompa-
nied by mild anterior uveitis and a vitreous inflamma-
tory reaction [6]. However, Toxoplasma parasites are
rarely detected in aqueous humor specimens from pa-
tients with ocular toxoplasmosis [7], which suggests that
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parasite proliferation occurs only during the early phase of in-
fection and that retinal damages may be attributable to subse-
quent inflammatory processes [8].
Recently, interleukin (IL)–17-producing effector T cells,
which are controlled by IL-27, were detected in inflamed brain
specimens infected with Toxoplasma [9]. A similar pathway is
found in experimental autoimmune uveoretinitis [10], which
suggests that an autoimmune inflammatory response might
contribute to bystander tissue destruction.
Aqueous humor cytokine and chemokine concentrations are
elevated in both infectious and noninfectious uveitis [11], and
more specific analysis might reveal the mechanisms of retinal
damage in uveitis. However, because of the difficulties involved
in obtaining aqueous humor samples and because of the limited
available specimen volumes (150 –200 L), ELISA can only pro-
vide quantitative profiles for 3 or 4 cytokines per sample [12].
Currently, with the advent of the multiplex bioassay (Bio-Plex;
Bio-Rad), up to 100 different molecules can be quantified simul-
taneously in a sample volume of 20 L.
In the present study, we used the multiplex assay to study the
profiles of 17 cytokines and chemokines in aqueous humor sam-
ples obtained from patients with ocular toxoplasmosis and viral
uveitis and compared these profiles with those in aqueous hu-
mor samples obtained from control subjects with intermediate
uveitis or cataract.
PATIENTS AND METHODS
Patients with ocular toxoplasmosis. Paired aqueous humor
and serum samples were obtained from 27 patients (14 female
and 13 male patients) aged 14 –78 years (mean age, 40 years)
after the patients provided informed consent, in accordance
with the Declaration of Helsinki (table 1). The samples were
obtained for routine diagnostic purposes from patients with an
active retinochoroidal lesion strongly evoking ocular toxoplas-
mosis who were seen in ophthalmology departments at 3 loca-
tions (Bern, Switzerland; Monastir, Tunisia; and Strasbourg,
France). Only 1 patient (patient 13; with ocular toxoplasmosis)
had been treated (with corticosteroids) before the aqueous hu-
mor sample was obtained. The serum samples were used to com-
pare intraocular cytokine levels with such levels in paired serum
samples. The diagnosis of ocular toxoplasmosis was confirmed
by using at least 1 of the following methods: (1) local specific IgG
antibody assay with the Goldmann-Witmer-Desmonts coeffi-
cient, the modified Goldmann-Witmer-Desmonts coefficient,
or immunoblot of paired aqueous humor and serum samples
[7]; (2) local specific IgA assay [13]; or (3) PCR amplification of
Toxoplasma DNA in aqueous humor specimens [7].
Patients with viral uveitis. The group of patients with viral
uveitis consisted of 14 patients (mean age, 60 years) with clini-
cally typical and polymerase chain reaction– confirmed herpes
simplex virus type 1 or varicella-zoster virus uveitis, as described
in detail elsewhere [14].
Patients with chronic noninfectious intermediate uveitis. Thir-
teen patients (mean age, 32 years) with chronic cellular vitreal infil-
tration of unknown etiology and without chorioretinal lesions (id-
iopathic uveitis or sarcoidosis) were included in the group with
intermediate uveitis.
Control group. The control group consisted of 22 patients
(mean age, 62 years) who had undergone routine cataract sur-
gery and had no evidence of any other intraocular pathology on
preoperative examination.
Sample collection and processing. Aqueous humor sam-
ples (100 –150 L) were collected by means of anterior cham-
ber paracentesis. Samples were immediately centrifuged at
20,000 g for 3 min, and the supernatant was stored in 25-L
aliquots at 20°C until analysis. Serum samples were stored
at 20°C.
Cytokine measurement in aqueous humor and serum
samples. The Bio-Plex Human Cytokine 17-Plex Panel as-
say (Bio-Rad) was used to measure cytokine and chemokine
levels in aqueous humor and serum samples. The immune
mediators were classified in 5 categories: (1) proinflamma-
tory mediators (IL-1, IL-6, IL-8, monocyte chemoattractant
protein [MCP]–1, and macrophage inflammatory protein
[MIP]–1), (2) type 1 cytokines (IL-2, IL-7, IL-12, interferon
[IFN]-, and tumor necrosis factor [TNF]–), (3) type 2 cy-
tokines (IL-4, IL-5, IL-10, and IL-13), (4) T helper (Th) 17
cytokine (IL-17), and (5) growth factors (granulocyte colony-
stimulating factor [G-CSF] and granulocyte monocyte
colony-stimulating factor [GM-CSF]).
The cytokine and chemokine assay plate layout consisted of 8
standards in duplicate (1–32,000 pg/mL), 1 blank well (for back-
ground fluorescence subtraction), and 50-L duplicates of each
aqueous humor or serum sample, diluted 3-fold with Bio-Plex
human serum diluent. The Bio-Plex method was performed as
recommended by the manufacturer.
Data were analyzed with Bio-Plex Manager software, version
1.1 (Bio-Rad). The index was calculated as the ratio of cytokine
concentration in patients with uveitis and the mean concentra-
tion plus 3 times the standard error of the mean for each cyto-
kine from the 22 patients with cataract. Indexes were calculated
for ocular toxoplasmosis, viral uveitis, and intermediate uveitis.
An index 5 was considered to be low positive, an index of 5–10
was considered to be medium positive, and an index 10 was
considered to be high.
Statistical analysis. The Kruskal-Wallis test was performed
using GraphPad Prism software, version 5, to compare the me-
dian titers of immune mediators among the 4 groups of patients.
Spearman rank correlation was used to detect correlations
among the different mediators.
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RESULTS
Comparison of Aqueous Humor and Serum Cytokine Profiles
in Patients with Ocular Toxoplasmosis
Paired serum and aqueous humor samples from 27 patients with
ocular toxoplasmosis were analyzed. Titers of MIP-1 and IL-7
were significantly lower in aqueous humor samples than in se-
rum samples, although IL-2 levels were similar in both types of
samples. The titers of the other 14 mediators were significantly
higher in aqueous humor samples than in serum samples.
Cytokine and Chemokine Profiles in Aqueous Humor
Samples
Proinflammatory mediators. IL-1, IL-6, IL-8, MCP-1, and
MIP-1 were detected in aqueous humor samples from 30%,
55%, 63%, 55%, and 55% of patients with ocular toxoplasmosis,
respectively (table 2). The levels of all of these mediators were
higher in samples from patients with ocular toxoplasmosis than
in samples from patients with cataract (P  .002), although
IL-8 and MIP-1 levels were higher in samples from patients
with ocular toxoplasmosis than in samples from patients with
intermediate uveitis (P  .03), and IL-6 and IL-8 levels were
lower in samples from patients with ocular toxoplasmosis than
in samples from patients with viral uveitis (P  .003) (figure 1).
Type 1 cytokines. IL-2, IL-7, IL-12, IFN-, and TNF- were
detected in samples from 18%, 15%, 52%, 67%, and 85% of
patients with ocular toxoplasmosis, respectively (table 2). Levels
of all cytokines, except for IL-7, were significantly higher in sam-
ples from patients with ocular toxoplasmosis than in samples
from patients with cataract (P  .001), although only IL-2 and
IL-12 levels were higher in samples from patients with ocular
plasmosis than in samples from patients with intermediate uve-
itis (P  .01) and in samples from patients with viral uveitis
(P  .01). IL-7, IFN-, and TNF- levels were similar in sam-
ples from patients with ocular toxoplasmosis, samples from pa-
tients with intermediate uveitis, and samples from patients with
viral uveitis (figure 2).
Type 2 cytokines. IL-4, IL-5, IL-10, and IL-13 were detected
in samples from 63%, 55%, 63%, and 7% of patients with ocular
toxoplasmosis, respectively (table 2). All of the type 2 cytokines
were up-regulated in patients with ocular toxoplasmosis, com-
pared with patients with cataract (P  .02). IL-4, IL-5, and
IL-10 levels were higher in samples from patients with ocular
toxoplasmosis than in samples from patients with intermediate
uveitis (P  .04), and the type 2 cytokine concentrations were
similar in samples from patients with ocular toxoplasmosis and
in samples from patients with viral uveitis (figure 3).
Growth factors. G-CSF was detected in samples from 44%
of patients with ocular toxoplasmosis (table 2). G-CSF levels
were higher in samples from patients with ocular toxoplasmosis
than in samples from patients with cataract (P  .001). Of in-
terest, GM-CSF levels were found to be significantly lower in
samples from patients with ocular toxoplasmosis than in sam-
ples from patients with cataract (P  .001) and in samples from
patients with viral uveitis (P  .001). Levels of both factors were
similar in samples from patients with ocular toxoplasmosis and
in samples from patients with intermediate uveitis (figure 4A).
Table 2. Profiles of immune mediators in different groups of uveitis.
Mediator
IU group VU group
Index, by patient
Patients,
no. (%)
Index, by patient
Patients,
no. (%)1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 14
IL-1  1 (8)        7 (50)
IL-6     4 (31)        7 (50)
IL-8      5 (54)             12 (86)
MCP-1          9 (69)           10 (71)
MIP-1    3 (23)          9 (64)
IL-2 0 0
IL-7 0   2 (14)
IL-12   2 (15)   2 (14)
IFN-     4 (31)         8 (57)
TNF-           10 (78)        7 (50)
IL-4        7 (54)         8 (57)
IL-5  1 (8)      5 (36)
IL-10         8 (61)             12 (86)
IL-13   2 (15)     4 (28)
IL-17        7 (54)   2 (14)
G-CSF        7 (54)         8 (57)
GM-CSF 0            11 (78)
NOTE. The index was calculated as the ratio of cytokine concentration in patients with uveitis and the mean concentration plus 3 times the standard error
of the mean for each cytokine from the patients with cataract. Lower production () was marked by an index 5, medium production () was marked by an
index of 5–10, and higher production () was marked by an index 10.
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Th17 cytokine. IL-17 was detected in samples from 70% of
patients with ocular toxoplasmosis (table 2). IL-17 levels were
higher in samples from patients with ocular toxoplasmosis than
in samples from patients with cataract (P  .001) and in sam-
ples from patients with viral uveitis (P  .001); however, IL-17
levels were not different between samples from patients with
ocular toxoplasmosis and samples from patients with interme-
diate uveitis (figure 4B).
Individual Variation of Immune Mediators
IL-6, IL-8, MCP-1, MIP-1, IL-12, IFN-, TNF-, IL-4, IL-5,
IL-10, and IL-17 were detected in of aqueous humor specimens
from 50% patients with ocular toxoplasmosis (table 2). Eight
patients (30%) with ocular toxoplasmosis had detectable IL-12
and IL-17. These cytokines were also found in samples from 2
patients (14%) with viral uveitis and in a sample from 1 patient
with intermediate uveitis (table 2). IL-8, MCP-1, IL-17, TNF-,
IL-4, IL-10, and G-CSF were up-regulated in samples from
50% of patients with intermediate uveitis; however, only 3 of
the 13 patients had detectable levels of all of these mediators
(Table 2). IL-1, IL-6, IL-8, MCP-1, MIP-1, IFN-, TNF-,
IL-4, IL-10, and growth factors were detected in samples from
50% of patients with viral uveitis; however, only 3 of the 14
patients had detectable levels of all of these mediators (table 2).
Of interest, 5 mediators (IL-8, MCP-1, TNF-, IL-4, and IL-
10) were detected in samples from 50% of patients in all
groups. In contrast, IL-5 and IL-12 were specific for ocular tox-
oplasmosis, and GM-CSF and IL-1 were specific for viral uveitis;
thus, these mediators could present specific markers for diag-
nostic purposes. Finally, IFN-, IL-6, and MIP-1 were fre-
quently detected in samples from patients with ocular toxoplas-
mosis and in samples from those with viral uveitis, whereas
IL-17 was frequently detected in samples from patients with oc-
ular toxoplasmosis and in samples from those with intermediate
uveitis (figure 5).
Correlation Between Mediator Levels in Aqueous Humor
Samples and Clinical Characteristics of Ocular
Toxoplasmosis
Local cytokine concentrations in patients with ocular toxoplas-
mosis did not correlate with age, sex, and region of origin of the
patient; time from symptom onset to the obtainment of samples;
the degree of uveal inflammation; or the etiology of the infection
(primary acquired or congenital).
DISCUSSION
We observed higher concentrations of several cytokines in aque-
ous humor samples than in serum samples. This may indicate
that these cytokines are locally secreted or that they are not
cleared from the eye as quickly as they are from the serum, per-
haps because there are fewer immune cells and, therefore, cyto-
kine receptors in the eye.
B cells and specific antibodies are abundant in human ocular
toxoplasmosis and, in addition to recruited macrophages, are
likely to play a protective role. Immunohistochemical studies
have shown a predominance of T cells and macrophages among
the inflammatory cells found in aqueous humor of fetuses and
Table 2. (Continued.)
Mediator
OT group
Index, by patient
Patients,
no. (%)1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
IL-1         8 (30)
IL-6                15 (55)
IL-8                  17 (63)
MCP-1                15 (55)
MIP-1                15 (55)
IL-2      5 (18)
IL-7     4 (15)
IL-12               14 (52)
IFN-                   18 (67)
TNF-                        23 (85)
IL-4                  17 (63)
IL-5                15 (55)
IL-10                  17 (63)
IL-13   2 (7)
IL-17                    19 (70)
G-CSF             12 (44)
GM-CSF 0
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infants with active disease [15]. The regulatory role of cytokines
in this situation is unclear. In mouse models of ocular toxoplas-
mosis, IFN-, TNF-, and nitric oxide play an important role,
mainly after primary infection, in the control of acquired ocular
toxoplasmosis [16]. The ambiguous role of proinflammatory
and immunoregulatory factors in intracellular and, namely, in-
traocular pathogen infections is still being debated [17]. Human
aqueous humor cytokine mapping may be the first step toward
addressing this issue.
Proinflammatory mediator (MCP-1, IL-8, and IL-6) levels
were increased in aqueous humor samples from patients with
ocular toxoplasmosis, as was reported elsewhere for patients
with viral uveitis [11]. During toxoplasmic uveitis, these proin-
flammatory mediators could be produced by Müller cells, retinal
pigment epithelial cells, or retinal vascular endothelial cells [18 –
20]. The mediators lead to the recruitment of neutrophils,
monocytes, and T lymphocytes, which are essential for clearing
the infection. MCP-1 is involved in the recruitment of a partic-
ular population of Gr-1 monocytes that are capable of lysing T.
gondii and other intracellular miccroorganisms [21]. Such in-
fected CD11c and CD11b monocytes were shown to dissem-
inate the infection to the brain in a mouse model [22]. In a
mouse model of retinal detachment [23], MCP-1 was shown to
play a central role in photoreceptor cell apoptosis and could,
thus, contribute to reduced visual acuity in the context of ocular
toxoplasmosis and to the triggering of an autoimmune process.
Figure 1. Proinflammatory cytokine levels in aqueous humor samples obtained from 22 patients with cataract (CAT), 13 patients with intermediate
uveitis (IU), 14 patients with viral uveitis (VU), and 27 patients with ocular toxoplasmosis (OT). Vertical lines represent median values, boxes represent
interquartile ranges, and whiskers represent minimum and maximum values. IL, interleukin; MCP, monocyte chemoattractant protein; MIP, macrophage
inflammatory protein. *P  .05, for OT vs. CAT, OT vs. IU, and OT vs. VU; **P  .001, for OT vs. CAT, OT vs. IU, and OT vs. VU.
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Local production of IL-8 in ocular toxoplasmosis and viral
uveitis appears to have a crucial role in neutrophil recruitment to
the eye [20]. It is noteworthy that mice lacking IL-8 are more
susceptible to T. gondii infection than are mice with detectable
IL-8 [24].
IL-6 was detected in the 2 forms of infectious uveitis: acute
and chronic intraocular inflammation. Müller cells may be a
source of IL-6 [20]. IL-6 is considered to be a strong proinflam-
matory mediator in the eye [25]. The high intraocular concen-
tration of IL-6 in ocular toxoplasmosis could add to the action of
chemokines and aggravate the destructive local inflammatory
response within the retina. IL-6 inhibits the activity of trans-
forming growth factor (TGF)–, an anti-inflammatory cyto-
kine. TGF- may be the key cytokine for maintenance of ante-
rior chamber–associated immune deviation, for control of
intraocular inflammation, and for maintenance of the integrity
of the eye [26]. On the other hand, IL-6 may also have a protec-
tive role against parasite proliferation, because T. gondii–in-
fected IL-6/ mice have higher parasite loads and more-severe
ocular inflammation, compared with IL-6/ mice [27].
Elevated local levels of IL-6 and TGF- have been found in
murine ocular toxoplasmosis. IL-6 seems to control the ocular
parasite burden and inflammatory activity, whereas TGF- (as a
regulator of the ocular immune privilege), in association with
IL-10 [28], limits inflammatory activity [27].
Type 1 cytokines play an important role in the control of tox-
oplasmic infection [29]. We found that ocular IL-12 levels were
significantly augmented in ocular toxoplasmosis; this might have
been responsible for the local IFN- and TNF- production ob-
served in most of our patients. Ocular IFN- and TNF- may have
2 effects in ocular toxoplasmosis: (1) limiting Toxoplasma prolifer-
ation [30] and (2) amplifying the local inflammatory reaction [31].
Figure 2. Type 1 cytokine levels in aqueous humor samples obtained from 22 patients with cataract (CAT), 13 patients with intermediate uveitis (IU),
14 patients with viral uveitis (VU), and 27 patients with ocular toxoplasmosis (OT). Vertical lines represent median values, boxes represent interquartile
ranges, and whiskers represent minimum and maximum values. IFN, interferon; IL, interleukin; TNF, tumor necrosis factor. *P  .05, for OT vs. CAT,
OT vs. IU, and OT vs. VU; **P  .001, for OT vs. CAT, OT vs. IU, and OT vs. VU.
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This may explain why Toxoplasma DNA was detected in an aqueous
humor sample from only 1 of the 17 patients with ocular toxoplas-
mosis in our study, possibly because of late presentation after symp-
tom onset (mean time from symptom onset to presentation, 22.8
days [range, 3–120 days]). Indeed, Toxoplasma undergoes a rapid
stage transition in the anterior chamber and is cleared by the
immune response [32]. Not surprisingly, IFN- and TNF- lev-
els were accordingly augmented in the group of patients with
viral uveitis. Studies of mouse models of viral necrotizing retini-
tis have revealed that herpes simplex virus type 1 infection leads
to a remarkable increase in IFN- and TNF- expression in cho-
rioretinal tissue [33]. Together, our data confirm the strong type
1 immune response during retinal infection by intracellular mi-
croorganisms [30].
Another pillar of inflammation is IL-17, produced by Th17
lymphocytes, a CD4 T cell subset that is considered to be
responsible for autoimmune inflammation [34], including
autoimmune uveoretinitis [10]. Recently, IL-17 was shown to
be involved in murine toxoplasmic encephalitis [9]. We
found for the first time, to our knowledge, that IL-17 was
up-regulated in 70% of patients with ocular toxoplasmosis. In
addition to its anti-Toxoplasma role [35, 36], IL-17 stimulates
the production of IL-6 and NO and amplifies the local inflam-
matory response in synergy with other mediators, such as
IL-1, TNF-, and IFN- [34]. Therefore, it is noteworthy that
TNF- and IFN- were both strongly up-regulated in our
patients with ocular toxoplasmosis. IL-17 also amplifies local
inflammatory responses by recruiting neutrophils and mono-
cytes to sites of infection through the production of IL-8,
MCP-1, growth-regulated oncogene–, and G-CSF [36, 37].
Finally, detection of IL-17 in aqueous humor samples from
patients with ocular toxoplasmosis supports the existence of
an autoimmune process that results from cytopathic effects to
damaged tissues, such as phagocytosis of photoreceptors and
retinal pigmented epithelial cells, in the context of ocular tox-
oplasmosis [38, 39]. It is highly probable that counterbalanc-
ing of IL-17 by retinal IL-27 occurs (not determined in our
series) [9, 10].
Type 2 cytokine up-regulation in ocular toxoplasmosis and in
viral uveitis, namely up-regulation of IL-4, IL-5, and IL-10, may
down-regulate the local inflammatory process by inhibiting IL-
12, TNF-–producing macrophages, or TbetFoxp3 lympho-
cytes [40 – 42]. Regulation of IL-10 –producing cells (Th1, Th2,
or even Th17 cells), found in one-third of the patients with oc-
ular toxoplasmosis in our study, seems to be complex, and one of
the possible pathways is controlled by IL-27 and TGF- [9, 43,
44].
IL-5 may also have a protective role [45]. It is required for the
production of eosinophils and for induction of protective anti-
bodies in adaptive immune responses; thus, it is associated with
enhancement of the Th2 response. In our study, 55% of patients
Figure 3. Type 2 cytokine levels in aqueous humor samples obtained from 22 patients with cataract (CAT), 13 patients with intermediate uveitis (IU),
14 patients with viral uveitis (VU), and 27 patients with ocular toxoplasmosis (OT). Vertical lines represent median values, boxes represent interquartile
ranges, and whiskers represent minimum and maximum values. IL, interleukin. *P  .05, for OT vs. CAT, OT vs. IU, and OT vs. VU; **P  .001, for
OT vs. CAT, OT vs. IU, and OT vs. VU.
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with ocular toxoplasmosis had high levels of IL-5, which was
associated with elevated production of IL-12 and IFN-. This
finding provides a new observation with regard to the role of
IL-5 in the regulation of IL-12 and IFN- (which was reported
elsewhere [46]). Moreover, IL-4, IL-5, and IL-10 may be respon-
sible for local IgG production during Toxoplasma infection [47].
Of interest, GM-CSF seemed to be specifically produced in
viral uveitis in our study; however, in a previous clinical study on
herpes uveitis, the authors did not find any GM-CSF in aqueous
humor samples [11]. In contrast to our findings for GM-CSF,
up-regulation of G-CSF occurred in the context of the other
forms of uveitis. G-CSF delays neutrophil apoptosis and may
thus prolong the inflammatory process in the eye [48].
We found a wide variation of cytokine levels produced among
all samples demonstrating uveitis. However, we found no corre-
lation between cytokine titers and clinical characteristics in oc-
ular toxoplasmosis, which suggests that genetic factors are in-
volved in cytokine production [49], as was shown in murine
ocular toxoplasmosis [50]. In this context, up-regulation of
IL-12 and IL-17 in the absence of GM-CSF seems to be a partic-
ularly interesting profile.
In conclusion, we observed wide interindividual variations in
local cytokine concentrations among samples obtained from pa-
tients with infectious uveitis. However, acute viral ocular infec-
tions result mostly in explosive production of chemokines, of
which GM-CSF is the most representative. In semichronic or
chronic uveitis, ocular toxoplasmosis or intermediate uveitis
shared Th1- and Th17-weighted local cytokine profiles; IL-5 and
IL-12 were more specific for ocular toxoplasmosis. These data
support the hypothesis of a microorganism-induced inflamma-
tory response that is probably derived from MCP-1 and IL-8
recruited monocytes, neutrophils, and T cells. Type 2 cytokine
response, observed in all 3 types of uveitis, counterbalances the
ongoing ocular inflammatory process. The ocular immuno-
privileged site thus creates such a counterproductive conse-
quence of its ability to specifically exclude infiltrating T cells and
macrophages. The resulting imbalance may result in the ob-
served retinal damage. Ocular cytokine mapping may, thereby,
not only contribute to a closer understanding of the pathophys-
iological characteristics underlying uveitis but also provide guid-
ance for the detection of new treatment targets, such as GM-
CSF, IL-17, IL-6, and even TNF-. This information may serve
Figure 4. Levels of T helper 17 cytokines (A) and growth factors (B) in aqueous humor samples obtained from 22 patients with cataract (CAT), 13
patients with intermediate uveitis (IU), 14 patients with viral uveitis (VU), and 27 patients with ocular toxoplasmosis (OT). Vertical lines represent median
values, boxes represent interquartile ranges, and whiskers represent minimum and maximum values. G-CSF, granulocyte colony-stimulating factor;
GM-CSF, granulocyte monocyte colony-stimulating factor; IL, interleukin.*P  .05, for OT vs. CAT, OT vs. IU, and OT vs. VU; **P  .001, for OT vs.
CAT, OT vs. IU, and OT vs. VU.
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as a rational basis to introduce targeted local use of cytokine
bioregulators.
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